Similar articles

• Prekallikrein activation and high-molecular-weight kininogen consumption in hereditary angioedema.

  Schapira M, Silver LD, Scott CF, Schmaier AH, Prograis LJ Jr, Curd JG, Colman RW. Schapira M, et al. N Engl J Med. 1983 May 5;308(18):1050-3. doi: 10.1056/NEJM198305053081802. N Engl J Med. 1983. PMID: 6601240
• Role of the second component of complement (C2) and plasmin in kinin release in hereditary angioneurotic edema (H.A.N.E.) plasma.

  Donaldson VH, Rosen FS, Bing DH. Donaldson VH, et al. Trans Assoc Am Physicians. 1977;90:174-83. Trans Assoc Am Physicians. 1977. PMID: 148134 No abstract available.
• Structural and functional characterization of factor XII.

  Tans G, Rosing J. Tans G, et al. Semin Thromb Hemost. 1987 Jan;13(1):1-14. doi: 10.1055/s-2007-1003471. Semin Thromb Hemost. 1987. PMID: 3551074 Review.
• Interactions of C1(-)-inhibitors from normal persons and patients with type II hereditary angioneurotic edema with purified activated Hageman factor (factor XIIa).

  Donaldson VH, Mitchell BH, Everson B, Ratnoff OD. Donaldson VH, et al. Blood. 1990 Feb 15;75(4):911-21. Blood. 1990. PMID: 2302459
• Complement, Kinins, and Hereditary Angioedema: Mechanisms of Plasma Instability when C1 Inhibitor is Absent.

  Kaplan AP, Joseph K. Kaplan AP, et al. Clin Rev Allergy Immunol. 2016 Oct;51(2):207-15. doi: 10.1007/s12016-016-8555-6. Clin Rev Allergy Immunol. 2016. PMID: 27273087 Review.